Connor Hagen

Connor Hagen's work experience includes a current position as a Research Scientist at Cybrexa Therapeutics starting from July 2021. Prior to that, they worked as a Research Technician at Memorial Sloan Kettering Cancer Center from October 2018 to June 2021. In 2016, they worked as an Undergraduate Research Assistant at the University of Connecticut, where they participated in research focused on testing the efficacy of a mosaic vaccine for multiple strains of Porcine Reproductive & Respiratory Syndrome.

Connor Hagen attended the University of Connecticut from 2014 to 2018, where they pursued a Bachelor of Science degree in Pathobiology and Molecular and Cell Biology. In addition, they also attended the University of Nottingham in 2017, where they studied in the Life Sciences Department. The degree pursued at the University of Nottingham is unknown.